Project Grant R01DK140347

Award Date 7/1/25
Completion Date 4/30/30
Dollars Obligated $488K
Federal Grant Program
93.847
Assistance Type
Project Grant
Place of Performance
Vermont, USA
Similar Awards
This federal Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), provides $546,503.00 to Duke University to conduct research on how the gut senses and communicates bitter stimuli to the brain. The research aims to determine how specialized gut cells called neuropod cells detect bitter compounds through taste receptors and signal this information to...
This federal Project Grant award, funded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), provides $747,500.00 to support research on memory formation in the enteric nervous system (ENS). The project aims to build the tools required for studying the formation and meaning of ENS memories, and then use these tools in combination with various perturbations to transform the...
This Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), provides $516,648 to The Leland Stanford Junior University to conduct research on understanding the mechanisms by which microbially derived metabolites regulate host gut inflammation. The award period runs from August 28, 2024 to February 28, 2027. The research aims to determine the regulatory...
This federal Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), under the CFDA 93.847 Diabetes, Digestive, and Kidney Diseases Extramural Research program, provides $196,940 to The General Hospital Corporation (doing business as Massachusetts General Hospital) to conduct a 5-year research project on a positive psychology intervention for irritable bowel syndrome (IBS). The key products and services to be delivered under this award include: 1)...
This Project Grant award of $168,900 from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) supports research to determine how the commensal bacterium Blautia activates signaling in gut epithelial cells to benefit host metabolism and mucosal health. The research aims to identify the synthetic processes and microbial products of Blautia that augment activation of enteroendocrine...
The National Institutes of Health National Institute of Diabetes and Digestive and Kidney Diseases awarded a $152,205 Project Grant to The Regents of the University of California San Francisco under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847). The grant funds research to investigate how vagal sensory neurons regulate autonomic responses to achieve metabolic homeostasis, and how downstream neuronal circuits in the nucleus tractus solitarius integrate...
This Project Grant award of $117,000.00 from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) supports research to investigate the role of substance P-mediated activation of mast cells in driving visceral hypersensitivity and barrier dysfunction in irritable bowel syndrome (IBS). The objective is to delineate the underlying mechanisms of bidirectional crosstalk between sensory...
This $147,486 Project Grant awarded by the National Institute of Diabetes and Digestive and Kidney Diseases (CFDA 93.847) will support research to investigate the impact of type 2 diabetes on the vaginal microbiome and its influence on susceptibility to the bacterial pathogen Group B Streptococcus (GBS). The research aims to define the homeostatic characteristics of the vaginal microenvironment in type 2 diabetes, and characterize how the diabetic vaginal microbiome interacts with GBS and...
This $484,314 Project Grant was awarded by the National Science Foundation (NSF) Division of Integrative Organismal Systems under the Biological Sciences program (CFDA 47.074). The funding will support research at Christopher Newport University to investigate the "microbiota-gut-brain axis" and the impact of intestinal barrier dysfunction on aging and neurodegeneration. Key objectives include gaining insights into the cellular and molecular changes associated with an aging gut, how...
This Project Grant award, totaling $216,736.00, was provided by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847). The research project aims to identify the mechanisms by which the host circadian clock and gut microbiome regulate mucus production in the large intestine to protect against infectious and chemical colitis. Key objectives include determining the specific microbiota...

This federal Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), provides $487,590 to the University of Vermont & State Agricultural College to conduct research on modulating gut and brain serotonin signaling using tryptophan-producing bacteria. The key objectives are to elucidate the mechanisms by which tryptophan-synthesizing bacteria enhance colonic motility, and to determine whether increased circulatory tryptophan from these gut bacteria can alter serotonin signaling in the brain and affect anxiety and depression. The project will run from July 1, 2025 to April 30, 2030.

Generated 8/5/25, 3:32 AM